drug protocol number

OBS17984

drug sponsor

Sanofi

drug study

iGlarLixi

drug trial site

King Fahad Medical City (Riyadh),King Fahad Specialist Hospital, Buraydah, Hira Hospital (Makkah) ,Al-AlSheikh Diabetes Cente (Riyadh)

drug status

Ongoing

drug phase